Related Experiment Video
Updated: May 26, 2025

10:31
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
Published on: January 13, 2022
9.2K
Enhancing sanitization for AVB Sepharose resin in AAV vector purification
Ruixi Wang1, Albert Kao1, Lu Wang1
1Process Development, Spark Therapeutics Inc., 3025 Market Street, Philadelphia, PA, 19104, United States.
Journal of Chromatography. A
|February 21, 2025
Summary
Effective cleaning protocols for affinity chromatography resins in gene therapy manufacturing were developed. These strategies reduce contamination risks and costs, enabling multiple uses of expensive resins without impacting product quality or yield.
Area of Science:
- Biotechnology
- Process Chemistry
- Gene Therapy Manufacturing
Background:
- Affinity chromatography is essential for capturing adeno-associated virus (AAV) vectors in gene therapy.
- High costs of affinity resins necessitate efficient cleaning and sanitization for multi-cycle use.
- Microbial contamination and product carryover are significant challenges in AAV purification.
Purpose of the Study:
- To develop and validate enhanced cleaning and sanitization protocols for affinity chromatography resins used in AAV purification.
- To identify effective reagent combinations against diverse microbial strains, including resistant species.
- To ensure multi-cycle resin usability without compromising process yield or product quality.
Main Methods:
- Evaluation of various cleaning reagent combinations, including alcohols, sodium hydroxide (NaOH), and acids.
- Testing efficacy against a broad spectrum of microbial strains, focusing on acid- and alkaline-resistant species.
- Implementation and validation of optimized pre-use and post-use cleaning strategies.
Main Results:
- A cleaning solution of 100 mM acetic acid with 2% benzyl alcohol and 10 mM NaOH with 2% benzyl alcohol proved effective.
- The developed strategy allowed for up to six column cycles with no product carryover.
- No compromise in process yield or product quality was observed with the new protocols.
Conclusions:
- The new cleaning and sanitization strategy provides effective microbial control for AAV purification using AVB Sepharose resin.
- This approach preserves resin integrity, reduces contamination risks, and lowers manufacturing costs.
- The validated protocols enhance the quality and reliability of gene therapy product manufacturing.

